德国拜耳利伐沙班的价格

Rivaroxaban is the world's first oral direct factor Xa inhibitor, mainly used to treat venous thrombosis in adults. Compared with traditional anticoagulants, Rivaroxaban has accurate efficacy, does not require constant monitoring, has good safety and is easy to use. It is expected to become an alternative drug to heparin and vitamin K antagonists.

At present, Rivaroxaban has been approved in more than 100 countries around the world and has been successfully marketed by Bayer in more than 75 countries. In June 2009, Rivaroxaban was officially launched in China and is used to prevent or reduce the formation of blood clots, deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip or knee replacement surgery.

Price of Rivaroxaban from Bayer in Germany: Rivaroxaban is available in two specifications: 20mg*28 tablets; 15mg*28 tablets, priced at about 350$. Affected by factors such as exchange rate fluctuations, prices are not fixed. If patients want to know the specific price information of rivaroxaban, they can consult the medical companion travel service.

The recommended initial dose of Rivaroxaban for the treatment of acute venous thrombosis (DVT) is 15 mg twice daily for the first three weeks, followed by 20 mg once daily for maintenance treatment and to reduce the risk of recurrent PE from DVT. Patients should note: Rivaroxaban 10 mg can be taken with food or alone. Rivaroxaban 15 mg or 20 mg tablets should be taken with food.

The recommended dose for preventing venous thrombosis in adult patients undergoing elective hip or knee replacement surgery is Rivaroxaban 10 mg orally once daily. If the wound has stopped bleeding, the first dose of medication should be between 6 and 10 hours after surgery.

The above is the introduction about Rivaroxaban. If patients have other questions about Rivaroxaban, they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/89964.html